Deutschland kommt bei der Bekämpfung von Infektionskrankheiten und antimikrobieller Resistenzen eine zentrale Rolle zu. Als Hochleistungsmedizinland kann Deutschland Innovationsmotor im Kampf gegen Infektionen sein. Mit der Deutschen Antibiotika-Resistenzstrategie DART2020 und massiver Unterstützung europäischer Initiativen wie der Global Antibiotic Research and Development Partnership hat Deutschland diesen Kampf in den vergangenen Jahren vorangetrieben. Trotz einzelner Erfolge dürfen die Anstrengungen nicht nachlassen.
One important aspect of equal opportunity is the ability to balance work and family life. The director of the institute is committed to meeting the special familial needs of female and male research scientists. This includes flexible work hours and the consideration of familial interests when making appointments and planning business meetings.
To optimize and expand on these and future measures, an “equal opportunity” workgroup was initiated at Leibniz-IPHT. Under the direction of the scientific director, this workgroup has made it its goal to identify the needs and suitable instruments necessary to implement and promote these measures in accordance with the policies of the Leibniz Association.
In accordance with a resolution issued by the Leibniz Association, the member institutions are required to certify their efforts in support of balancing work and family life. Leibniz-IPHT has received the “Total E-Quality” distinction. Companies and institutions that pursue an organizational and personnel policy based on equal opportunity, which recognizes, promotes, and integrates the talent, competence, and potential of gender equality, are awarded this honor.